Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Merck wins first FDA approval for Keytruda as a treatment for mesothelioma
Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a treatment for malignant plural mesothelioma, a rare cancer associated with asbestos.
Merck's Keytruda Obtains its First FDA Approval for Mesothelioma
Merck & Co., Inc. MRK announced that the FDA had approved its blockbuster anti-PD-1 therapy, Keytruda (pembrolizumab), for a new indication. The regulatory body has now approved Keytruda in combination with pemetrexed and platinum chemotherapy for the first-line treatment of adult patients with unresectable advanced or metastatic malignant pleural mesothelioma (MPM).
USFDA nod to Merck KEYTRUDA plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S.Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination
Keytruda Plus Chemotherapy Approved for Malignant Pleural Mesothelioma
The FDA has approved Keytruda in combination with pemetrexed and platinum chemotherapy, as first-line Tx of unresectable advanced or metastatic malignant pleural mesothelioma.
FDA Approves Frontline Pembrolizumab/Chemotherapy in Advanced Mesothelioma
Pembrolizumab plus chemotherapy is now an approved frontline treatment for patients with unresectable advanced or metastatic malignant pleural mesothelioma.
Pembrolizumab Approved With Chemotherapy for Malignant Pleural Mesothelioma
Pembrolizumab (Keytruda, Merck) has picked up another indication — this time for the first-line treatment of unresectable advanced or metastatic malignant pleural mesothelioma (MPM) in combination with pemetrexed and platinum chemotherapy.
Merck: KEYTRUDA Plus Chemotherapy Gets FDA Approval For Malignant Pleural Mesothelioma In Adults
Drug major Merck & Co., Inc. (MRK) announced Wednesday that the U.S. Food and Drug Administration has approved its anti-PD-1 therapy
Merck’s Keytruda label expanded in the U.S. for mesothelioma
Merck (NYSE:MRK) announced Wednesday that the U.S. Food and Drug Administration (FDA) approved a label expansion for its blockbuster therapy Keytruda to allow its use as a first-line combination therapy for mesothelioma,
5d
$39M Jury Verdict Awarded in Novel Mesothelioma Case
Plaintiffs' lead attorney Mark Linder emphasized this is the first mesothelioma lawsuit that proceeded from this type of ...
Times Star
5h
Inquest: Michael Lee of Cleator died due to mesothelioma
AN inquest has been opened into the death of a Cleator man who suffered from a form of lung cancer associated with exposure to asbestos. Michael Lee, 74, died at his home on Hilden Road on July 1, ...
FiercePharma
7d
J&J talc appeal upends $260M award to Oregon woman with mesothelioma
Three months after a jury awarded $260 million to an Oregon woman who claimed her use of Johnson’s Baby Powder caused her to ...
1d
Best Mesothelioma Lawyers San Antonio, TX Of 2024
Mesothelioma is among the most dangerous illnesses that result from asbestos exposure. It involves tumors, typically ...
Naturopathic Doctor News
7d
Gut Bacteria & Mesothelioma
Mesothelioma, caused by asbestos exposure, is an aggressive form of cancer with no cure; treatments attempt to improve/expand ...
The Brighterside of News on MSN
4d
Breakthrough cancer treatment destroys advanced-stage tumors in under 6 days
Researchers from Rice University and Baylor College of Medicine have demonstrated a groundbreaking treatment that eradicates ...
4d
Best Mesothelioma Lawyers Dallas, TX Of 2024
For decades, shipyard workers at Texas ports, Texas oil refinery workers and U.S. soldiers at Dallas-area bases inhaled ...
3d
Son of Cannock mine worker appealing for help after seeing father's 'unjust' and 'painful' death
The son of a former mining surveyor has spoken of the anguish of discovering his father's asbestos-related cancer diagnosis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Pembrolizumab
Keytruda
Merck & Co.
Food and Drug Administration
Feedback